Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2970-2973

  Hoshi, Saichi ^a,b   Kikuchi, Ken ^a   Sasaki, Takashi ^a   Sotozono, Chie ^b   Kinoshita, Shigeru ^b   Hiramatsu, Keiichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BROTH DILUTION; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION ROUTES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; OPHTHALMIC SOLUTIONS; STAPHYLOCOCCUS AUREUS;

EID: 48749103513     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01466-07     Document Type: Article

References (35)

1. Alexandrakis, G., E. C. Alfonso, and D. Miller. 2000. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107:1497-1502.
2. Ba, B. B., C. Arpin, C. Vidaillac, A. Chausse, M.-C. Saux, and C. Quentin. 2006. Activity of gatifloxacin in an in vitro pharmacokinetic- pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrob. Agents Chemother. 50:1931-1936.
3. Chongtrakool, P., T. Ito, X. X. Ma, Y. Kondo, S. Trakulsomboon, C. Tiensasitorn, M. Jamklang, T. Chavalit, J.-H. Song, and K. Hiramatsu. 2006. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob. Agents Chemother. 50:1001-1012.
4. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, MD.
6. Dajcs, J. J., B. A. Thibodeaux, M. E. Marquart, D. O. Girgis, M. Traidej, and R. J. O'Callaghan. 2004. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrob. Agents Chemother. 48:1948-1952.
7. Gangopadhyay, N., M. Daniell, L. Weih, and H. R. Taylor. 2000. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br. J. Ophthalmol. 84:378-384.
8. Goldstein, M. H., R. P. Kowalski, and Y. J. Gordon. 1999. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 106:1313-1318.
9. Horii, T., Y. Suzuki, A. Takeshita, and M. Maekawa. 2007. Molecular characterization of 8-methoxyfluoroquinolone resistance in a clinical isolate of methicillin-resistant Staphylococcus aureus. Chemotherapy (Basel) 53:104-109.
10. Iihara, H., T. Suzuki, Y. Kawamura, K. Ohkusu, Y. Inoue, W. Zhang, M. M. Shah, Y. Katagiri, Y. Ohashi, and T. Ezaki. 2006. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. Diagn. Microbiol. Infect. Dis. 56:297-303.
11. Ince, D., and D. C. Hooper. 2001. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus. Antimicrob. Agents Chemother. 45:2755-2764.
12. Kamo, J., H. Yamamoto, S. Muramatsu, and A. Unno. 2006. Kinds of bacteria from conjunctivitis discharge at both ward and clinic and their susceptibility to drugs 2001-2005. Atarashii Ganka 23:219-224. (In Japanese.)
13. Kikuchi, K., N. Takahashi, C. Piao, K. Totsuka, H. Nishida, and T. Uchiyama. 2003. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J. Clin. Microbiol. 41:3001-3006.
14. Kotulus, B. S., R. A. Wymbs, E. M. Vellozzi, and I. J. Udell. 2006. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates. Am. J. Ophthalmol. 142:726-729.
15. Licata, L., C. E. Smith, R. M. Goldschmidt, J. F. Barrett, and M. Frosco. 1997. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:950-955.
16. Lloyd, P., T. Mallari, D. J. McCarty, M. Daniell, and H. Taylor. 2001. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am. J. Ophthalmol. 131:131-133.
17. Marangon, F. B., D. Miller, M. S. Muallem, A. C. Romano, and E. C. Alfonso. 2004. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am. J. Ophthalmol. 137:453-458.
18. Moshirfar, M., V. Feiz, A. T. Vitale, J. A. Wegelin, S. Basavanthappa, and D. H. Wolsey. 2007. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones. Ophthalmology 114:686-691.
19. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
20. Noguchi, N., H. Okada, K. Narui, and M. Sasatsu. 2004. Comparison of the nucleoside sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Microb. Drug Resist. 10:197-203.
21. Noguchi, N., T. Okihara, Y. Namiki, Y. Kumaki, Y. Yamanaka, M. Koyama, K. Wakasugi, and M. Sasatsu. 2005. Susceptibility and resistance gene to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. Int. J. Antimicrob. Agents 25:374-379.
22. Oliveira, D. C., A. Tomasz, and H. de Lencastre. 2002. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:180-189.
23. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1999. Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms. Antimicrob. Agents Chemother. 43:2574-2575.
24. Piao, C., T. Karasawa, K. Totsuka, T. Uchiyama, and K. Kikuchi. 2005. Prospective surveillance of community-onset and healthcare-associated methicillin-resistant Staphylococcus aureus isolated from a university-affiliated hospital in Japan. Microbiol. Immunol. 49:959-970.
25. Raizman, M. B., J. M. Rubin, A. L. Graves, and M. Rinehart. 2002. Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers. Clin. Ther. 24:1439-1450.
26. Romanowski, E. G., F. S. Mah, K. A. Yates, R. P. Koalski, and J. Gordon. 2005. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar® (gatifloxacin 0.3%) in a NZW rabbit model. Am. J. Ophthalmol. 139:867-877.
27. Rutar, T., H. F. Chambers, J. B. Crawford, F. Perdreau-Remington, O. M. Zwick, M. Karr, J. J. Diehn, and K. P. Cockerham. 2006. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology 113:1455-1462.
28. Rutar, T., O. M. Zwick, K. P. Cockerham, and J. C. Horton. 2005. Bilateral blindness from orbital cellulitis caused by community-acquired methicillin-resistant Staphylococcus aureus. Am. J. Ophthalmol. 140:740-742.
29. Solomon, R., E. D. Donnenfeld, H. D. Perry, R. S. Rubinfeld, M. Ehrenhaus, J. R. Wittpenn, K. D. Solomon, E. E. Manche, M. Moshirfar, D. C. Matzkin, R. M. Mozayeni, and R. K. Maloney. 2007. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery. Am. J. Ophthalmol. 143:629-634.
30. Sotozono, C., K. Inagaki, A. Fujita, N. Koizumi, Y. Sano, T. Inatomi, and S. Kinoshita. 2002. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infectious in the cornea. Cornea 21(Suppl. 2):S94-S101.
31. Wada, T., T. Tajika, H. Takahashi, H. Sakaki, and Y. Miyagawa. 2004. Postantibiotic effect of gatifloxacin in ophthalmic use. Atarashii Ganka 21:1520-1524. (In Japanese.)
32. Walter, K., and M. E. Tyler. 2006. Severe corneal toxicity after topical fluoroquinolone therapy, report of two cases. Cornea 25:855-857.
33. Wilhelmus, K. R., R. L. Abshire, and B. A. Schlech. 2003. Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis. Arch. Ophthalmol. 121:1229-1233.
34. Wroblewski, K. J., J. F. Pasternak, K. S. Bower, S. C. Schallhorn, W. J. Hubickey, C. E. Harrison, M. F. Torres, and S. D. Barnes. 2006. Infectious keratitis after photorefractive keratectomy in the United States army and navy. Ophthalmology 113:520-525.
35. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.